Cargando…

Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is a heterogeneous disease with aggressive biology and complex tumor evolution. Our purpose was to identify enrichment patterns of genomic alterations in metastatic triple-negative breast cancer (mTNBC). METHODS: Genomic data were retrieved (mutations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saravia, César H, Flores, Claudio, Schwarz, Luis J, Bravo, Leny, Zavaleta, Jenny, Araujo, Jhajaira, Neciosup, Silvia, Pinto, Joseph A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689917/ https://www.ncbi.nlm.nih.gov/pubmed/31447598 http://dx.doi.org/10.1177/1179554919868482

Ejemplares similares

Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America
por: Pinto, Joseph A, et al.
Publicado: (2019)

Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
por: Araujo, Jhajaira M., et al.
Publicado: (2018)

Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key
por: Rabanal, Connie, et al.
Publicado: (2017)

Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer
por: de la Cruz-Ku, Gabriel, et al.
Publicado: (2020)

PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report
por: Valencia, Guillermo Arturo, et al.
Publicado: (2021)

Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience
por: De-la-Cruz-Ku, Gabriel, et al.
Publicado: (2020)

Control of cervical cancer in Peru: Current barriers and challenges for the future
por: Aguilar, Alfredo, et al.
Publicado: (2016)

In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies
por: Pinto, Joseph A., et al.
Publicado: (2017)

Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes
por: Araujo, Jhajaira M., et al.
Publicado: (2022)

Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer
por: Araujo, Jhajaira M., et al.
Publicado: (2016)

A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease
por: Pinto, Joseph A, et al.
Publicado: (2016)

Immunotherapy in triple-negative breast cancer: A literature review and new advances
por: Valencia, Guillermo Arturo, et al.
Publicado: (2022)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
por: Ferreyra, Yomali, et al.
Publicado: (2023)

Subpopulation treatment effect pattern plot analysis: a prognostic model for distant recurrence-free survival to estimate delayed adjuvant chemotherapy initiation effect in triple-negative breast cancer
por: Morante, Zaida, et al.
Publicado: (2023)

Standard of Care and Promising New Agents for Triple Negative Metastatic Breast Cancer
por: Mancini, Patrizia, et al.
Publicado: (2014)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
por: Jin, Jia, et al.
Publicado: (2018)

Metastatic and triple-negative breast cancer: challenges and treatment options
por: Al-Mahmood, Sumayah, et al.
Publicado: (2018)

How I treat metastatic triple-negative breast cancer
por: Caparica, Rafael, et al.
Publicado: (2019)

Overview of recent advances in metastatic triple negative breast cancer
por: O'Reilly, David, et al.
Publicado: (2021)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
por: Heeke, Arielle L., et al.
Publicado: (2021)

Emerging treatment strategies for metastatic triple-negative breast cancer
por: Huppert, Laura A., et al.
Publicado: (2022)

Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice
por: O’Shaughnessy, Joyce, et al.
Publicado: (2021)

Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Huang, Yunxia, et al.
Publicado: (2023)

Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer
por: Dameri, Martina, et al.
Publicado: (2021)

LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2020)

Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort
por: Martini, Rachel, et al.
Publicado: (2021)

AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature
por: Davis, Melissa, et al.
Publicado: (2018)

BRCA2 Mutations and Triple-Negative Breast Cancer
por: Meyer, Peter, et al.
Publicado: (2012)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
por: Fernandez, Sandra V, et al.
Publicado: (2014)

Circulating tumor cells in non-metastatic triple-negative breast cancer
por: Karhade, Mandar, et al.
Publicado: (2014)

A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
por: Zeichner, Simon B., et al.
Publicado: (2016)

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
por: Cazzaniga, M. E., et al.
Publicado: (2017)

Practical consensus recommendations on management of triple-negative metastatic breast cancer
por: Rangarao, R., et al.
Publicado: (2018)

Sacituzumab Govitecan for Treatment of Refractory Triple-Negative Metastatic Breast Cancer
por: Fleming, Patrick J., et al.
Publicado: (2021)

Optimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast Carcinoma
por: Sflomos, George, et al.
Publicado: (2023)

[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo
por: Martin, Ana Carolina B.M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j5oatecni9r220naqr6gie5tbf